SG145775A1 - Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells - Google Patents

Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells

Info

Publication number: SG145775A1
Authority: SG; Singapore
Prior art keywords: cells; particle; cryopreservation; transplantation; culture
Prior art date: 2003-09-02

Application number

SG200806368-7A

Other languages

English (en)

Inventor

Arron S L Xu

Lola M Reid

Original Assignee

Univ North Carolina

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-02

Filing date

2004-09-01

Publication date

2008-09-29

2004-09-01 Application filed by Univ North Carolina filed Critical Univ North Carolina

2008-09-29 Publication of SG145775A1 publication Critical patent/SG145775A1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Developmental Biology & Embryology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Materials For Medical Uses (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)

SG200806368-7A 2003-09-02 2004-09-01 Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells SG145775A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US49902303P	2003-09-02	2003-09-02

Publications (1)

Publication Number	Publication Date
SG145775A1 true SG145775A1 (en)	2008-09-29

Family

ID=34272762

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG200806368-7A SG145775A1 (en)	2003-09-02	2004-09-01	Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells

Country Status (12)

Country	Link
US (2)	US20050100877A1 (ru)
EP (1)	EP1660653A4 (ru)
JP (1)	JP2007503840A (ru)
CN (1)	CN1875101A (ru)
AU (1)	AU2004269405A1 (ru)
BR (1)	BRPI0413207A (ru)
CA (1)	CA2537509A1 (ru)
MX (1)	MXPA06002440A (ru)
NO (1)	NO20061480L (ru)
RU (1)	RU2006110526A (ru)
SG (1)	SG145775A1 (ru)
WO (1)	WO2005021730A2 (ru)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080220520A1 (en) *	2003-11-19	2008-09-11	Palecek Sean P	Cryopreservation of human embryonic stem cells in microwells
US20050106554A1 (en) *	2003-11-19	2005-05-19	Palecek Sean P.	Cryopreservation of pluripotent stem cells
US7534449B2 (en) *	2004-07-01	2009-05-19	Yale University	Targeted and high density drug loaded polymeric materials
WO2007001448A2 (en)	2004-11-04	2007-01-04	Massachusetts Institute Of Technology	Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
WO2006128216A1 (en) *	2005-05-30	2006-12-07	Commonwealth Scientific And Industrial Research Organisation	Preparation and use of basement membrane particles
JP5763288B2 (ja) *	2005-11-17	2015-08-12	日本全薬工業株式会社	細胞保存用水溶液
US9267937B2 (en) *	2005-12-15	2016-02-23	Massachusetts Institute Of Technology	System for screening particles
ES2776100T3 (es)	2006-03-31	2020-07-29	Massachusetts Inst Technology	Sistema para el suministro dirigido de agentes terapéuticos
EP2019691B1 (en)	2006-05-15	2020-08-12	Massachusetts Institute of Technology	Polymers for functional particles
WO2007150030A2 (en) *	2006-06-23	2007-12-27	Massachusetts Institute Of Technology	Microfluidic synthesis of organic nanoparticles
CN100428964C (zh) *	2006-06-29	2008-10-29	武汉理工大学	RGD多肽接枝聚(羟基乙酸-L-赖氨酸-L-乳酸)/β-磷酸三钙复合材料及其制备方法
US20100144845A1 (en) *	2006-08-04	2010-06-10	Massachusetts Institute Of Technology	Oligonucleotide systems for targeted intracellular delivery
WO2008098165A2 (en) *	2007-02-09	2008-08-14	Massachusetts Institute Of Technology	Oscillating cell culture bioreactor
US10265407B2 (en)	2007-02-15	2019-04-23	Yale University	Modular nanodevices for smart adaptable vaccines
WO2008115641A2 (en)	2007-02-15	2008-09-25	Yale University	Modular nanoparticles for adaptable vaccines
US20090074828A1 (en) *	2007-04-04	2009-03-19	Massachusetts Institute Of Technology	Poly(amino acid) targeting moieties
WO2008124634A1 (en)	2007-04-04	2008-10-16	Massachusetts Institute Of Technology	Polymer-encapsulated reverse micelles
EP2217269B1 (en)	2007-10-12	2017-04-12	Massachusetts Institute of Technology	Vaccine nanotechnology
GB0721081D0 (en) *	2007-10-26	2007-12-05	Metcalfe Susan M	Immuno-modulatory composition
US11051733B2 (en) *	2008-01-18	2021-07-06	Wake Forest University Health Sciences	Isolating and purifying cells for therapy
US8172831B2 (en)	2008-09-02	2012-05-08	Abbott Cardiovascular Systems Inc.	Catheter configured for incremental rotation
US8591905B2 (en)	2008-10-12	2013-11-26	The Brigham And Women's Hospital, Inc.	Nicotine immunonanotherapeutics
US8343498B2 (en)	2008-10-12	2013-01-01	Massachusetts Institute Of Technology	Adjuvant incorporation in immunonanotherapeutics
US8277812B2 (en)	2008-10-12	2012-10-02	Massachusetts Institute Of Technology	Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
US8343497B2 (en)	2008-10-12	2013-01-01	The Brigham And Women's Hospital, Inc.	Targeting of antigen presenting cells with immunonanotherapeutics
US8603532B2 (en)	2008-10-20	2013-12-10	Massachusetts Institute Of Technology	Nanostructures for drug delivery
US8956867B2 (en) *	2008-11-07	2015-02-17	Wisconsin Alumni Research Foundation	Method for culturing stem cells
WO2010099463A2 (en)	2009-02-27	2010-09-02	University Of Pittsburgh-Of The Commonwealth System Of Higher Education	Joint bioscaffolds
WO2010120385A1 (en) *	2009-04-18	2010-10-21	Massachusetts Institute Of Technology	pH SENSITIVE BIODEGRADABLE POLYMERIC PARTICLES FOR DRUG DELIVERY
US8956863B2 (en)	2009-10-15	2015-02-17	The Brigham And Women's Hospital, Inc.	Agents from cells
AR081906A1 (es) *	2010-05-07	2012-10-31	Univ North Carolina	Metodo para injertar celulas de tejidos solidos, reparar tejidos, para localizar celulas, metodo de crioconservacion, injerto de tejido
WO2012068243A2 (en) *	2010-11-16	2012-05-24	Ingeneron, Inc.	Methods for obtaining target cells
WO2012068248A2 (en) *	2010-11-16	2012-05-24	Ingeneron, Inc.	Methods for preserving target cells
US9597385B2 (en)	2012-04-23	2017-03-21	Allertein Therapeutics, Llc	Nanoparticles for treatment of allergy
EP2852617B1 (en) *	2012-05-22	2018-12-12	Life Technologies AS	Recombinant antibody compositions and methods of use thereof
WO2014031883A1 (en)	2012-08-23	2014-02-27	Susan Marie Metcalfe	Neurotherapeutic nanoparticle compositions and devices
US20160022872A1 (en) *	2013-03-06	2016-01-28	University Of Pittsburgh-Of The Commonwealth System Of Higher Education	Cell-based compositions, cell-based bandage devices and systems and methods of treatment therewith
EP3760223A1 (en)	2013-04-03	2021-01-06	N-Fold Llc	Nanoparticle composition for desensitizing a subject to peanut allergens
CA3113645A1 (en) *	2018-09-20	2020-03-26	Arizona Board Of Regents On Behalf Of The University Of Arizona	Targeting moiety-drug grafted immune cell compositions and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4839058A (en) *	1982-09-13	1989-06-13	Cawley Leo P	On-line plasma modification method
US4861714A (en) *	1985-04-04	1989-08-29	Verax Corporation	Weighted collagen microsponge for immobilizing bioactive material
US4999283A (en) *	1986-01-10	1991-03-12	University Of Kentucky Research Foundation	Method for x and y spermatozoa separation
US5266480A (en) *	1986-04-18	1993-11-30	Advanced Tissue Sciences, Inc.	Three-dimensional skin culture system
US6500608B2 (en) *	1998-10-14	2002-12-31	Katrina T. Forest	Method for vitrification of biological cells
DK1147179T3 (da) *	1999-01-19	2009-03-09	Univ North Carolina	Humane lever-progenitorer
DE60121450T2 (de) *	2000-08-16	2007-02-15	Duke University	Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe

2004
- 2004-09-01 SG SG200806368-7A patent/SG145775A1/en unknown
- 2004-09-01 WO PCT/US2004/028193 patent/WO2005021730A2/en active Application Filing
- 2004-09-01 BR BRPI0413207-6A patent/BRPI0413207A/pt not_active IP Right Cessation
- 2004-09-01 JP JP2006526145A patent/JP2007503840A/ja active Pending
- 2004-09-01 CN CNA2004800316583A patent/CN1875101A/zh active Pending
- 2004-09-01 MX MXPA06002440A patent/MXPA06002440A/es not_active Application Discontinuation
- 2004-09-01 EP EP04782630A patent/EP1660653A4/en not_active Withdrawn
- 2004-09-01 CA CA002537509A patent/CA2537509A1/en not_active Abandoned
- 2004-09-01 US US10/931,073 patent/US20050100877A1/en not_active Abandoned
- 2004-09-01 RU RU2006110526/15A patent/RU2006110526A/ru not_active Application Discontinuation
- 2004-09-01 AU AU2004269405A patent/AU2004269405A1/en not_active Abandoned
2006
- 2006-03-31 NO NO20061480A patent/NO20061480L/no not_active Application Discontinuation
- 2006-07-12 US US11/484,615 patent/US20070042341A1/en not_active Abandoned

Also Published As

Publication number	Publication date
RU2006110526A (ru)	2007-10-10
US20050100877A1 (en)	2005-05-12
CA2537509A1 (en)	2005-03-10
AU2004269405A1 (en)	2005-03-10
EP1660653A2 (en)	2006-05-31
JP2007503840A (ja)	2007-03-01
WO2005021730A2 (en)	2005-03-10
EP1660653A4 (en)	2007-10-03
WO2005021730A3 (en)	2005-07-28
MXPA06002440A (es)	2006-06-20
CN1875101A (zh)	2006-12-06
US20070042341A1 (en)	2007-02-22
NO20061480L (no)	2006-06-02
BRPI0413207A (pt)	2006-10-03

Publication	Publication Date	Title
SG145775A1 (en)	2008-09-29	Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells
Temenoff et al.	2004	In vitro osteogenic differentiation of marrow stromal cells encapsulated in biodegradable hydrogels
CA2442135A1 (en)	2002-10-03	Methods to culture circovirus
DE69941599D1 (de)	2009-12-10	Zusammensetzungen von zu schnellem wachstum fähigen, restriktierten zellen, die proliferation unterdrückende materialien produzieren und ihre verwendung
TR199903123T2 (xx)	2000-05-22	Anti-Vegf antikorlar�.
HK1081981A1 (en)	2006-05-26	Compositions and methods for coating food cans
EP2336187A3 (en)	2012-01-11	Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
EP2055325A3 (en)	2014-01-15	Tissue regenerative composition
TR200200897T2 (tr)	2002-08-21	Melez matrisler ve melez matriks karışımları
WO2004111800A3 (en)	2007-07-05	Dynamic adjustment of bins in mail sorting
MXPA03008882A (es)	2003-12-08	Composiciones y metodos utiles para la infeccion por hcv.
AU2003288621A1 (en)	2004-07-22	Rna bioassay
WO1999009167A8 (en)	1999-05-20	Porcine mhc class i genes and uses thereof
EP2377922A3 (en)	2013-05-29	PDX1 expressing endoderm
DE60042700D1 (de)	2009-09-17	Integrin-vermittelte arzneimittel-zielrichtung
GB2379446A (en)	2003-03-12	Cells,culture methods and their uses
DE60330223D1 (ru)	2010-01-07
DE69934399D1 (de)	2007-01-25	Komplex aus peptid und mhc-peptid auf oberfläche von phagen
ATE352609T1 (de)	2007-02-15	Mastzellkulturen aus dem schwein und deren verwendungen
MXPA05008687A (es)	2005-10-05	Remedio para cancer.
WO2000040604A3 (en)	2000-11-09	METHODS AND COMPOSITIONS FOR MODULATING CYTOKINE RELEASE BY αEβ7-EXPRESSING CELLS
Ando	2004	Novel bone and cartilage tissue engineering using a scaffold-free, synovium-derived implant: In vitro performance